Advertisement

BIOspektrum

, Volume 25, Issue 7, pp 715–718 | Cite as

Cytochrome P450 — vielseitige Enzyme für Medizin und Biotechnologie

  • Vlada B. UrlacherEmail author
  • Rita BernhardtEmail author
Biotechnologie
  • 12 Downloads

Abstract

Cytochromes P450 are heme containing enzymes that catalyze numerous oxidation reactions including hydroxylation of non-activated CH-bonds, epoxidation, dealkylation and even C-C bond cleavage. Along with their broad substrate spectrum, P450s often possess high regio-, chemo-, and stereoselectivity, thereby playing an essential role in metabolism. Due to their versatility P450s are the rising stars in biotechnological applications and synthetic biology.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Bernhardt R (2006) Cytochromes P450 as versatile biocatalysts. J Biotechnol 124:128–145CrossRefGoogle Scholar
  2. [2]
    Bernhardt R, Urlacher VB (2014) Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl Microbiol Biotechnol 98:6185–6203CrossRefGoogle Scholar
  3. [3]
    Omura T (2018) Future perception in P450 research. J Inorg Biochem 186:264–266CrossRefGoogle Scholar
  4. [4]
    Nelson DR (2018) Cytochrome P450 diversity in the tree of life. Biochim Biophys Acta Proteins Proteom 1866:141–154CrossRefGoogle Scholar
  5. [5]
    Schiffer L, Brixius-Anderko S, Hannemann F et al. (2016) Metabolism of oral turinabol by human steroid hormone-synthesizing cytochrome P450 enzymes. Drug Metab Dispos 44:227–237CrossRefGoogle Scholar
  6. [6]
    Schiffer L, Muller AR, Hobler A et al. (2016) Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: characterization of the products and their influence on mineralocorticoid receptor transactivation. J Steroid Biochem Mol Biol 163:68–76CrossRefGoogle Scholar
  7. [7]
    Rendic S, Guengerich FP (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem Res Toxicol 28:38–42CrossRefGoogle Scholar
  8. [8]
    Meyer UA (1996) Overview of enzymes of drug metabolism. J Pharmacokinet Biopharm 24:449–459CrossRefGoogle Scholar
  9. [9]
    Ingelman-Sundberg M, Sim SC, Gomez A et al. (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526CrossRefGoogle Scholar
  10. [10]
    Schuster I, Bernhardt R (2007) Inhibition of cytochromes p450: existing and new promising therapeutic targets. Drug Metab Rev 39:481–499CrossRefGoogle Scholar
  11. [11]
    Litzenburger M, Kern F, Khatri Y et al. (2015) Conversions of tricyclic antidepressants and antipsychotics with selected P450s from Sorangium cellulosum So ce56. Drug Metab Dispos 43:392–399CrossRefGoogle Scholar
  12. [12]
    Worsch A, Eggimann FK, Girhard M et al. (2018) A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s. Biotechnol Bioeng 115:2156–2166CrossRefGoogle Scholar
  13. [13]
    Zhang K, Shafer BM, Demars MD et al. (2012) Controlled oxidation of remote sp3 C-H bonds in artemisinin via P450 catalysts with fine-tuned regio- and stereoselectivity. J Am Chem Soc 134:18695–18704CrossRefGoogle Scholar
  14. [14]
    Le-Huu P, Heidt T, Claasen B et al. (2015) Chemo-, regio-,and stereoselective oxidation of the monocyclic diterpenoid β-cembrenediol by P450 BM3. ACS Catalysis 5:1772–1780CrossRefGoogle Scholar
  15. [15]
    Brandenberg OF, Fasan R, Arnold FH (2017) Exploiting and engineering hemoproteins for abiological carbene and nitrene transfer reactions. Curr Opin Biotechnol 47:102–111CrossRefGoogle Scholar
  16. [16]
    Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12:355–367CrossRefGoogle Scholar
  17. [17]
    Ajikumar PK, Xiao WH, Tyo KEJ et al. (2010) Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70–74CrossRefGoogle Scholar
  18. [18]
    Urlacher VB, Girhard M (2019) Cytochrome P450 monooxygenases in biotechnology and synthetic biology. Trends Biotechnol 37:882–897CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2019

Authors and Affiliations

  1. 1.Institut fur BiochemieHeinrich-Heine-Universitat DusseldorfDüsseldorfDeutschland
  2. 2.Universitat des SaarlandesInstitut fur BiochemieSaarbrückenDeutschland

Personalised recommendations